Cargando…

A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants

The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xuanyi, Warner, Jeremy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026022/
https://www.ncbi.nlm.nih.gov/pubmed/32117976
http://dx.doi.org/10.3389/fcell.2020.00048
_version_ 1783498601752690688
author Li, Xuanyi
Warner, Jeremy L.
author_facet Li, Xuanyi
Warner, Jeremy L.
author_sort Li, Xuanyi
collection PubMed
description The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology.
format Online
Article
Text
id pubmed-7026022
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-70260222020-02-28 A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants Li, Xuanyi Warner, Jeremy L. Front Cell Dev Biol Cell and Developmental Biology The increased availability of tumor genetic testing and targeted cancer therapies contributes to the advancement of precision medicine in the field of oncology. Precision oncology knowledgebases provide a way of organizing clinically relevant genetic information in a way that is easily accessible for both oncologists and patients, facilitating the genetic-based clinical decision making. Many organizations and companies have built precision oncology knowledgebases, intended for multiple users. In general, these knowledgebases offer information on cancer-related genetic variants as well as their associated diagnostic, prognostic, and therapeutic implications, but they often differ in their information curations, designs, and user experiences. It is advisable that oncologists use multiple knowledgebases during their practice to have them complement each other. In the future, convergence toward common standards and formats is needed to ensure that the comprehensive knowledge across all sources can be unified to bring the oncology community closer to the achievement of the goal of precision oncology. Frontiers Media S.A. 2020-02-11 /pmc/articles/PMC7026022/ /pubmed/32117976 http://dx.doi.org/10.3389/fcell.2020.00048 Text en Copyright © 2020 Li and Warner. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Li, Xuanyi
Warner, Jeremy L.
A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
title A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
title_full A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
title_fullStr A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
title_full_unstemmed A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
title_short A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants
title_sort review of precision oncology knowledgebases for determining the clinical actionability of genetic variants
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026022/
https://www.ncbi.nlm.nih.gov/pubmed/32117976
http://dx.doi.org/10.3389/fcell.2020.00048
work_keys_str_mv AT lixuanyi areviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants
AT warnerjeremyl areviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants
AT lixuanyi reviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants
AT warnerjeremyl reviewofprecisiononcologyknowledgebasesfordeterminingtheclinicalactionabilityofgeneticvariants